Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France; LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France
European Laboratory of the Investigation of Food Induced Diseases, Department of Translational Medical Science, Section of Pediatrics, and ELFID, University Federico II
Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France; LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France
Departamento de Fisiopatología, Hospital de Clínicas, Facultad de Medicina, Universidad de la República/ Laboratorio de Genómica Funcional, Institut Pasteur de Montevideo
Division of Immunology, LCMN, Germans Trias i Pujol University Hospital and Research Institute, Barcelona, Spain. Department of Cellular Biology, Physiology and Immunology, Autonomous University of Barcelona, Barcelona, Spain.
Hematology Department, Institut Català d’Oncologia de Badalona, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona. Universitat Autonòma de Barcelona, Spain. Universitat de Vic – Universitat Central de Catalunya, Spain.
Unidad de Inmunología, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República,/ Área Inmunología, Departamento de Biociencias, Facultad de Química, Universidad de la República
Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France; LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France
Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France; LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France
Hematology Department, Institut Català d’Oncologia de Badalona, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona. Universitat Autonòma de Barcelona, Spain.
Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France; LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France
Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France; LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France
Department of Internal Medicine, Geriatric Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain ; Universitat de Barcelona, Barcelona, Spain
Hematology Department, Institut Català d’Oncologia de Badalona, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona. Universitat Autonòma de Barcelona, Spain.
Centro de Nefrología, Hospital de Clínicas, Facultad de Medicina, Universidad de la República/Departamento de Inmunobiología, Facultad de Medicina, Universidad de la República
Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France; LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France
Centro de Nefrología, Hospital de Clínicas, Facultad de Medicina, Universidad de la República/ Departamento de Fisiopatología, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
European Laboratory of the Investigation of Food Induced Diseases, Department of Translational Medical Science, Section of Pediatrics, and ELFID, University Federico II
Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, F-44000 Nantes, France; LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France